$2.63 Billion is the total value of Slate Path Capital LP's 16 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $203,794,000 | -17.0% | 605,000 | -19.3% | 7.74% | -35.6% |
| PODD | Sell | INSULET CORP | $143,411,000 | +16.8% | 2,795,000 | -1.9% | 5.45% | -9.4% |
| TIF | Sell | TIFFANY & CO NEW | $142,213,000 | -10.1% | 1,515,000 | -8.7% | 5.40% | -30.2% |
| GDX | Sell | VANECK VECTORS ETF TRgold miners etf | $130,714,000 | -25.0% | 5,920,000 | -22.6% | 4.96% | -41.8% |
| AAP | Sell | ADVANCE AUTO PARTS INC | $121,837,000 | -24.6% | 1,045,000 | -4.1% | 4.63% | -41.5% |
| TSO | Sell | TESORO CORP | $110,448,000 | -24.9% | 1,180,000 | -35.0% | 4.20% | -41.7% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $90,528,000 | -11.7% | 1,135,000 | -43.2% | 3.44% | -31.4% |
| MDCO | Sell | MEDICINES CO | $20,715,000 | -37.7% | 545,000 | -19.9% | 0.79% | -51.6% |
| SSW | Sell | SEASPAN CORP | $3,213,000 | -17.2% | 450,000 | -19.6% | 0.12% | -35.8% |
| DXCM | Exit | DEXCOM INC | $0 | – | -1,119,500 | -100.0% | -4.64% | – |
| X | Exit | UNITED STATES STL CORP NEW | $0 | – | -3,115,000 | -100.0% | -5.15% | – |
| XLF | Exit | SELECT SECTOR SPDR TRsbi int-finl | $0 | – | -12,060,000 | -100.0% | -14.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.